Operation Manager | Pharmidex |
Senior Investment Associate | Cambridge Enterprise Ltd |
Director External Innovation | Johnson & Johnson Innovation |
Commercial Analyst & Researcher | Entoplast Ltd |
Chief Executive Officer | Rare Biotech Ltd |
Postdoctoral Research Scientist | The Francis Crick Institute |
CEO | Cambridge Medixine Ltd |
Chief Scientific Officer | Ikarovec Limited |
Chief Executive Officer | Arjuna Therapeutics |
Project Research Scientist | The Francis Crick Institute |
Co-Founder | imphatec |
CEO | Novai Ltd |
Co-Founder & CEO | Neobe Therapeutics Ltd |
CEO | Link Biologics Ltd |
Co-Founder and CEO | Plurify Bio |
Director | Medicon |
Founder | Woost |
Co-Founder | ReFleks |
Co-Founder and CEO | Bastion Therapeutics |
CEO | MFX |
Chief Operating Officer | Ultromics |
CEO | Cellestial Health |
CEO | P.Happi |
Founder | Natural Negative |
People and Culture Consultant | Neobe Therapeutics Ltd |
Head of Business Development | MediSieve Limited |
CEO | Mitra Bio |
Co-Founder and CEO | IntelligenceQ |
CEO | CipherX Technologies Ltd |
Director | Consone AI |
Chief Scientific Officer and Founder | GeneOmics Solutions Ltd |
VP Operations & Product Owner | MFX |
CEO & Co-Founder | VasoDynamics Ltd |
CEO | Ramanomics |
Senior Communications and Marketing Manager | National Institute for Health Research (NIHR) |
Director | Entoplast Ltd |
CEO | Nanograb Limited |
Co-founder, Director and CEO | ImmuONE Ltd |
CO-Founder and CEO | Plurify Bio |
Deputy Director, Business Growth | Innovate UK |
Post Doctoral Research Associate | Queen Mary University of London (QMUL) |
Founder & CEO | Extracellular Ltd |
CEO | MOMO Biotech Ltd |
Investor | Hummingbird Ventures |
Ecosystem Innovation Growth Specialist | Innovate UK |
Business Development Manager | Cambridge Consultants Ltd |
Founder and CEO | BRAINCURES |
CEO | Bioscopic |
Technology Transfer Fellow | LifeArc |
Business Development Manager | Pharmidex |
Principal | APEX Ventures |
CEO | The Vaccine Group |
CEO / Co-Founder | Ensilicated Technologies Ltd |
Founder and Prof of Experimental Hepatology | HepatiCan Ltd |
Director of Target & Drug Discovery | Pear Bio |
Investment Director | UK Innovation & Science Seed Fund |
Managing Director | Centaur Bio |
Ceo | Anti Microbial industry |
Post doc | Imperial College London |
Owner | Spicer & Spicer Ltd |
CEO | Immutrin Ltd |
CEO & Executive Director | Stablepharma Ltd |
CEO | Abselion |
CTO | Radiant Matter Ltd |
Chief Technology Officer | Kuano |
Co-founder | Panthura |
CEO | Tailor Bio |
Postgraduate | Imperial College London |
BD director | Syngene International |

BioStart is a quarterly newsletter explicitly designed for innovative, early-stage, entrepreneurs from the life sciences and biotech industry, where we'll be sharing everything money, space and people! Sign up to the newsletter here. You can also join the linkedin group here.
BIA Innovation Map
While there are many organisations and initiatives aimed at supporting early-stage companies, identifying the right one for where your business is right now can be difficult. The Innovation Map is a directory of accelerators, incubators and other support organisations that enables you to start narrowing down which offers are right for you, and help your company develop to its full potential.
Questions? Contact the team.

Chloe Hartley
Event Manager, BIA

Chloe Hartley
Event Manager, BIA
What does your role at BIA involve?
Chloe's role involves planning and executing large-scale events involving conferences, dinners and exhibitions.
Previous experience
She has previously worked at the Royal College of Psychiatrists in the events department, organising conferences and workshops for doctors.
If you could invite any scientist or entrepreneur to dinner, who would it be and why?
It would probably be Andrew Carnegie because he had a strong moral compass and built public libraries, theatres and child welfare centres to help better the community.